This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: October 14, 2022
Source: https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/
Reason: Acquired by Ipsen
Last recorded trade on: October 14, 2022
Source: https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/
Epizyme
EPZM
$2.05
Share price
0.00%
Change (1 day)
-65.26%
Change (1 year)
Categories
Unfortunately we have no P/E ratio historical data for this company